Dmitry Balyasny’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.4M | Buy |
45,766
+44,645
| +3,983% | +$13.6M | 0.02% | 817 |
|
|
2026
Q1 | $281K | Sell |
1,121
-54
| -5% | -$13.4K | ﹤0.01% | 2582 |
|
|
2025
Q4 | $323K | Sell |
1,175
-44,498
| -97% | -$12.2M | ﹤0.01% | 2701 |
|
|
2025
Q3 | $12M | Buy |
+45,673
| New | +$11.1M | 0.02% | 961 |
|
|
2025
Q1 | – | Sell |
-35,624
| Closed | -$11.7M | – | 3351 |
|
|
2024
Q4 | $11.7M | Buy |
+35,624
| New | +$11.2M | 0.02% | 895 |
|
|
2024
Q3 | – | Sell |
-4,148
| Closed | -$1.37M | – | 3215 |
|
|
2024
Q2 | $1.37M | Sell |
4,148
-3,034
| -42% | -$1.07M | ﹤0.01% | 1674 |
|
|
2024
Q1 | $2.84M | Sell |
7,182
-206,343
| -97% | -$76.3M | 0.01% | 1427 |
|
|
2023
Q4 | $75.2M | Buy |
213,525
+6,521
| +3% | +$2.31M | 0.14% | 173 |
|
|
2023
Q3 | $77.7M | Buy |
+207,004
| New | +$80.1M | 0.16% | 158 |
|
|
2023
Q1 | – | Sell |
-21,065
| Closed | -$4.96M | – | 3214 |
|
|
2022
Q4 | $4.96M | Buy |
+21,065
| New | +$4.99M | 0.01% | 1036 |
|
|
2021
Q4 | – | Sell |
-15,150
| Closed | -$6.43M | – | 2633 |
|
|
2021
Q3 | $6.43M | Buy |
+15,150
| New | +$6.39M | 0.03% | 736 |
|
|
2021
Q1 | – | Sell |
-28,646
| Closed | -$8.12M | – | 2115 |
|
|
2020
Q4 | $8.12M | Sell |
28,646
-20,208
| -41% | -$5.67M | 0.05% | 493 |
|
|
2020
Q3 | $13.4M | Buy |
48,854
+38,506
| +372% | +$10.2M | 0.1% | 305 |
|
|
2020
Q2 | $2.35M | Buy |
+10,348
| New | +$2.03M | 0.02% | 686 |
|
|
2019
Q4 | – | Sell |
-2,983
| Closed | -$423K | – | 1535 |
|
|
2019
Q3 | $423K | Sell |
2,983
-16,502
| -85% | -$2.27M | ﹤0.01% | 971 |
|
|
2019
Q2 | $2.44M | Buy |
+19,485
| New | +$2.3M | 0.02% | 819 |
|
|
2019
Q1 | – | Sell |
-8,305
| Closed | -$814K | – | 1692 |
|
|
2018
Q4 | $814K | Buy |
+8,305
| New | +$901K | 0.01% | 964 |
|
|
2018
Q2 | – | Sell |
-17,229
| Closed | -$1.52M | – | 2191 |
|
|
2018
Q1 | $1.52M | Buy |
17,229
+8,179
| +90% | +$765K | 0.01% | 1076 |
|
|
2017
Q4 | $893K | Buy |
9,050
+3,826
| +73% | +$375K | ﹤0.01% | 1372 |
|
|
2017
Q3 | $503K | Sell |
5,224
-3,638
| -41% | -$329K | ﹤0.01% | 1356 |
|
|
2017
Q2 | $838K | Sell |
8,862
-4,331
| -33% | -$398K | ﹤0.01% | 1150 |
|
|
2017
Q1 | $1.08M | Buy |
13,193
+6,893
| +109% | +$576K | 0.01% | 1073 |
|
|
2016
Q4 | $534K | Buy |
+6,300
| New | +$495K | ﹤0.01% | 1136 |
|
Other funds holding WST
GIM
Dmitry Balyasny's WST Position: Q2 2026 in Review
Dmitry Balyasny increased its West Pharmaceutical (WST) stake by 3,983% in Q2 2026, buying an estimated $13.6M and bringing the position to 45,766 shares worth $16.4M. The position accounts for 0.02% of the portfolio, ranked #817.
Dmitry Balyasny first reported a position in WST in Q4 2016 and has held it in 23 quarters since. The position peaked at $77.7M in Q3 2023. 827 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Dmitry Balyasny held 45,766 shares of West Pharmaceutical worth $16.4M as of Q2 2026.
- Dmitry Balyasny bought 44,645 West Pharmaceutical shares in Q2 2026, an estimated $13.6M.
- West Pharmaceutical made up 0.02% of Dmitry Balyasny's portfolio in Q2 2026, its #817 holding.
- Dmitry Balyasny first reported a position in West Pharmaceutical in Q4 2016 and has held it in 23 quarters since.
- Dmitry Balyasny's West Pharmaceutical position peaked at $77.7M in Q3 2023.
- 827 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.